scholarly article | Q13442814 |
P50 | author | Hisanori Minakami | Q61835770 |
Junko Tomikawa | Q84570923 | ||
Kazuhiko Nakabayashi | Q89157681 | ||
P2093 | author name string | Kenichiro Hata | |
Kentaro Matsuoka | |||
Kiyoko Kato | |||
Norio Wake | |||
Takahiro Yamada | |||
Yuko Yamaguchi | |||
Chiharu Tayama | |||
Rina Akaishi | |||
Hiromi Kamura | |||
P2860 | cites work | The H19 gene imprinting in normal pregnancy and pre-eclampsia. | Q54488113 |
Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction | Q58623881 | ||
Decreased Placental Methylation at the H19/IGF2 Imprinting Control Region is Associated with Normotensive Intrauterine Growth Restriction but not Preeclampsia | Q58623886 | ||
Pre-eclampsia | Q59546003 | ||
H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis | Q61795796 | ||
Japanese and North American/European patients with Beckwith-Wiedemann syndrome have different frequencies of some epigenetic and genetic alterations | Q80799580 | ||
Insulin-like growth factor II activates phosphatidylinositol 3-kinase-protooncogenic protein kinase 1 and mitogen-activated protein kinase cell Signaling pathways, and stimulates migration of ovine trophectoderm cells | Q80869288 | ||
Hypomethylation along with increased H19 expression in placentas from pregnancies complicated with fetal growth restriction | Q82729385 | ||
Differential expression of imprinted genes in normal and IUGR human placentas | Q83955454 | ||
Aberrant methylation of H19-DMR acquired after implantation was dissimilar in soma versus placenta of patients with Beckwith-Wiedemann syndrome | Q84109294 | ||
Beckwith-Wiedemann syndrome | Q84116019 | ||
Combined Single-Cell Profiling of lncRNAs and Functional Screening Reveals that H19 Is Pivotal for Embryonic Hematopoietic Stem Cell Development | Q91028493 | ||
H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas | Q92023364 | ||
LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury | Q92283097 | ||
Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform | Q25257477 | ||
The role and interaction of imprinted genes in human fetal growth | Q28083223 | ||
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene | Q28145754 | ||
Disruption of imprinting caused by deletion of the H19 gene region in mice | Q28287765 | ||
Complementary roles of genes regulated by two paternally methylated imprinted regions on chromosomes 7 and 12 in mouse placentation | Q33254717 | ||
Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer. | Q33325473 | ||
Preeclampsia, of mice and women | Q33432708 | ||
Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions | Q34047321 | ||
Parthenogenetic chimaerism/mosaicism with a Silver-Russell syndrome-like phenotype. | Q34289568 | ||
Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia | Q35079406 | ||
Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes | Q35197831 | ||
More than insulator: multiple roles of CTCF at the H19-Igf2 imprinted domain. | Q36316644 | ||
Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels. | Q36448418 | ||
Epigenetic deregulation of imprinting in congenital diseases of aberrant growth | Q36449310 | ||
Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. | Q36820044 | ||
The prevalence of loss of imprinting of H19 and IGF2 at birth. | Q37022907 | ||
H19 long noncoding RNA alters trophoblast cell migration and invasion by regulating TβR3 in placentae with fetal growth restriction | Q37437510 | ||
Genomic imprinting in germ cells: imprints are under control. | Q37760667 | ||
Placental pathology in early-onset and late-onset fetal growth restriction | Q38191785 | ||
Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth. | Q38880458 | ||
Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol | Q38884321 | ||
Fetal growth restriction: current knowledge. | Q39174725 | ||
Placental biomarkers for assessing fetal health | Q39359850 | ||
QUMA: quantification tool for methylation analysis | Q39786938 | ||
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements | Q40587967 | ||
Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer | Q40766020 | ||
Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region | Q41726237 | ||
Insulin-like growth factor II affects the appearance and glycogen content of glycogen cells in the murine placenta | Q42516475 | ||
Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction | Q45816443 | ||
Disproportional effects of Igf2 knockout on placental morphology and diffusional exchange characteristics in the mouse. | Q46148910 | ||
Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome | Q48126284 | ||
Molecular and clinical findings and their correlations in Silver-Russell syndrome: implications for a positive role of IGF2 in growth determination and differential imprinting regulation of the IGF2-H19 domain in bodies and placentas. | Q49112560 | ||
Developmental adaptations to increased fetal nutrient demand in mouse genetic models of Igf2-mediated overgrowth. | Q51889900 | ||
Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. | Q51954217 | ||
Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions. | Q52109754 | ||
A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. | Q52241373 | ||
Insulin-like growth factor (IGF)-I stimulates proliferation and migration of mouse ectoplacental cone cells, while IGF-II transforms them into trophoblastic giant cells in vitro. | Q52273441 | ||
P433 | issue | 1 | |
P304 | page(s) | 113 | |
P577 | publication date | 2019-08-01 | |
P1433 | published in | Clinical Epigenetics | Q18620113 |
P1476 | title | Placenta-specific epimutation at H19-DMR among common pregnancy complications: its frequency and effect on the expression patterns of H19 and IGF2 | |
P478 | volume | 11 |
Search more.